A61K 35/74
Bacteria
Official title: Bacteria (therapeutic use of a bacterial protein A61K38/00)
A61K35/74 (Bacteria) appears on 4,424 US grants and 8,659 published applications in this corpus.
Search patents in A61K- Granted patents
- 4,424
- Published applications
- 8,659
- Assignees
- 2,817
- Inventors
- 12,847
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 16 | 0 |
| 1978 | 4 | 0 |
| 1979 | 8 | 0 |
| 1980 | 11 | 0 |
| 1981 | 4 | 0 |
| 1982 | 13 | 0 |
| 1983 | 4 | 0 |
| 1984 | 10 | 0 |
| 1985 | 10 | 0 |
| 1986 | 5 | 0 |
| 1987 | 8 | 0 |
| 1988 | 6 | 0 |
| 1989 | 10 | 0 |
| 1990 | 4 | 0 |
| 1991 | 4 | 0 |
| 1992 | 5 | 0 |
| 1993 | 6 | 0 |
| 1994 | 9 | 0 |
| 1995 | 13 | 0 |
| 1996 | 13 | 0 |
| 1997 | 15 | 0 |
| 1998 | 24 | 0 |
| 1999 | 21 | 0 |
| 2000 | 27 | 0 |
| 2001 | 31 | 11 |
| 2002 | 40 | 57 |
| 2003 | 43 | 65 |
| 2004 | 32 | 122 |
| 2005 | 32 | 121 |
| 2006 | 38 | 111 |
| 2007 | 33 | 114 |
| 2008 | 25 | 125 |
| 2009 | 37 | 148 |
| 2010 | 56 | 186 |
| 2011 | 74 | 208 |
| 2012 | 71 | 224 |
| 2013 | 125 | 241 |
| 2014 | 131 | 304 |
| 2015 | 144 | 319 |
| 2016 | 202 | 377 |
| 2017 | 237 | 441 |
| 2018 | 260 | 464 |
| 2019 | 282 | 541 |
| 2020 | 311 | 630 |
| 2021 | 354 | 691 |
| 2022 | 379 | 731 |
| 2023 | 345 | 684 |
| 2024 | 328 | 709 |
| 2025 | 316 | 600 |
| 2026 | 241 | 435 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tumor-targeting Salmonella gallinarum strain and use thereof6 Oct 2026US 12,751,978 B2Industry Foundation of Chonnam National University
- Composition for preventing or treating inflammatory bowel disease6 Oct 2026US 12,751,979 B2Ajou University Industry-Academic Cooperation Foundation
- Bifidobacterium longum CCFM1206 capable of producing sulforaphane and relieving inflammation6 Oct 2026US 12,751,980 B2Jiangnan University
- Composition for improving the microbiome6 Oct 2026US 12,751,981 B2Iiaa Limited
- Oral and intestinal health products6 Oct 2026US 12,751,985 B2
- Probiotic-fortified, high-protein food product and method of making same8 Oct 2026US 2026/0305659 A1
- Method of addressing alzheimer's disease or non-alzheimer's dementia8 Oct 2026US 2026/0305670 A1G. Nofar Food Agency Ltd.
- Pharmaceutical combination for cancer treatment8 Oct 2026US 2026/0306466 A1Miyarisan Pharmaceutical Co., Ltd.
- Microbiome-based GABA Cream with Chondroitin Sulfate Transdermal Delivery System8 Oct 2026US 2026/0306531 A1
- Recombinant expression vector for interferon-beta secretion and attenuated salmonella strain transformed by means of same8 Oct 2026US 2026/0306554 A1The Industry & Academic Cooperation in Chungnam National University (IAC)
Most cited
By later US patents
- Synergistic bacterial compositions and methods of production and use thereof242US 9,028,841 B2Seres Health, Inc. · 2015
- Probiotic recolonisation therapy240US 8,460,648 B22013
- Compositions and methods239US 9,011,834 B1Seres Health, Inc. · 2015
- Treatment of gastro-intestinal disorders232US 6,645,530 B1Gastro Services Pty Ltd. · 2003
- Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli229US 5,443,826 A1995